Detalhe da pesquisa
1.
Identification of pathogenic variant enriched regions across genes and gene families.
Genome Res
; 30(1): 62-71, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871067
2.
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Nature
; 543(7645): 428-432, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273064
3.
Pharmacogenomics for immunotherapy and immune-related cardiotoxicity.
Hum Mol Genet
; 29(R2): R186-R196, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620943
4.
Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
Hum Mol Genet
; 29(R2): R177-R185, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601683
5.
Comprehensive characterization of protein-protein interactions perturbed by disease mutations.
Nat Genet
; 53(3): 342-353, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558758
6.
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.
Nat Cancer
; 2(1): 66-82, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738458
7.
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer.
Cancer Discov
; 9(6): 722-737, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015319